Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO®, JESPECT®) in a pediatric population in JE non-endemic countries: An uncontrolled, open-label phase 3 study - Concepedia

Concepedia

Publication | Open Access

Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO®, JESPECT®) in a pediatric population in JE non-endemic countries: An uncontrolled, open-label phase 3 study

DOI Full Paper Access

21

Citations

13

References

2018

Year

Tomáš Jelı́nek, Michael A. Cromer, Jakob P. Cramer, Deborah J Mills, Kenneth Lessans, Anthony Gherardin, Elizabeth D. Barnett, Stefan Hagmann, Helena Hervius Askling, Sigrid Kiermayr,

Travel Medicine and Infectious Disease

Abstract

IXIARO<sup>®</sup> was generally well tolerated in children, with an overall AE profile similar to adults. IXIARO<sup>®</sup> was highly immunogenic in both dose groups.

References

	Year	Citations

Page 1